Published in Proc Natl Acad Sci U S A on February 15, 2000
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58
Cas9 as a versatile tool for engineering biology. Nat Methods (2013) 6.87
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol (2014) 6.85
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A (2003) 6.37
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res (2006) 3.95
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol (2015) 3.56
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res (2013) 3.50
Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection. Proc Natl Acad Sci U S A (2003) 3.29
Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nat Methods (2013) 3.26
PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. Genes Dev (2002) 3.17
A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol (2001) 3.12
Next-generation synthetic gene networks. Nat Biotechnol (2009) 3.12
Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays. Nat Protoc (2009) 3.01
An affinity-based scoring scheme for predicting DNA-binding activities of modularly assembled zinc-finger proteins. Nucleic Acids Res (2008) 2.42
Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc Natl Acad Sci U S A (2003) 2.24
Improved DNA binding specificity from polyzinc finger peptides by using strings of two-finger units. Proc Natl Acad Sci U S A (2001) 2.13
Synthesis of programmable integrases. Proc Natl Acad Sci U S A (2009) 1.94
Dissecting neural function using targeted genome engineering technologies. ACS Chem Neurosci (2012) 1.89
Design of polyzinc finger peptides with structured linkers. Proc Natl Acad Sci U S A (2001) 1.88
Modular system for the construction of zinc-finger libraries and proteins. Nat Protoc (2010) 1.87
Site-directed transposon integration in human cells. Nucleic Acids Res (2007) 1.74
Light-inducible spatiotemporal control of gene activation by customizable zinc finger transcription factors. J Am Chem Soc (2012) 1.69
Targeted transcriptional repression using a chimeric TALE-SRDX repressor protein. Plant Mol Biol (2011) 1.57
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities. Nucleic Acids Res (2003) 1.48
A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat Chem Biol (2015) 1.48
Genome-editing Technologies for Gene and Cell Therapy. Mol Ther (2016) 1.41
Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res (2012) 1.38
Zinc finger nucleases as tools to understand and treat human diseases. BMC Med (2010) 1.36
Heritable endogenous gene regulation in plants with designed polydactyl zinc finger transcription factors. Proc Natl Acad Sci U S A (2002) 1.34
Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods (2015) 1.27
Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods (2016) 1.24
Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc Natl Acad Sci U S A (2003) 1.21
Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites. J Virol (2004) 1.20
Directed evolution of recombinase specificity by split gene reassembly. Nucleic Acids Res (2010) 1.19
Phenotypic alteration and target gene identification using combinatorial libraries of zinc finger proteins in prokaryotic cells. J Bacteriol (2005) 1.13
Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors. Proc Natl Acad Sci U S A (2003) 1.10
Strong DNA binding by covalently linked dimeric Lac headpiece: evidence for the crucial role of the hinge helices. Proc Natl Acad Sci U S A (2001) 1.09
Directed evolution of the TALE N-terminal domain for recognition of all 5' bases. Nucleic Acids Res (2013) 1.08
Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site. J Virol (2006) 1.07
Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies. Acc Chem Res (2014) 1.06
Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders. Am J Hum Genet (2015) 1.00
Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels. Nucleic Acids Res (2005) 1.00
Zinc-binding cysteines: diverse functions and structural motifs. Biomolecules (2014) 1.00
Toward design-based engineering of industrial microbes. Curr Opin Microbiol (2010) 0.99
Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT Locus. Mol Ther Nucleic Acids (2013) 0.97
Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene. Nucleic Acids Res (2003) 0.97
Regulation of transgene expression in plants with polydactyl zinc finger transcription factors. Proc Natl Acad Sci U S A (2002) 0.96
Novel domain combinations in proteins encoded by chimeric transcripts. Bioinformatics (2012) 0.96
Transduction of artificial transcriptional regulatory proteins into human cells. Nucleic Acids Res (2008) 0.95
Regulation of endogenous human gene expression by ligand-inducible TALE transcription factors. ACS Synth Biol (2013) 0.94
Gene therapy for hemophilia. Front Biosci (Landmark Ed) (2015) 0.94
Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression. Methods (2014) 0.93
Epigenome engineering in cancer: fairytale or a realistic path to the clinic? Front Oncol (2015) 0.92
Genetic and genomic toolbox of the chordate Ciona intestinalis. Genetics (2012) 0.91
Activating human genes with zinc finger proteins, transcription activator-like effectors and CRISPR/Cas9 for gene therapy and regenerative medicine. Expert Opin Ther Targets (2014) 0.90
Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther (2008) 0.90
Transcriptional repression of Gata3 is essential for early B cell commitment. Immunity (2013) 0.89
Positive selection of DNA-protein interactions in mammalian cells through phenotypic coupling with retrovirus production. Nat Struct Mol Biol (2009) 0.88
Structure-based design of a dimeric RNA-peptide complex. EMBO J (2001) 0.87
Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367. Nucleic Acids Res (2014) 0.87
The New State of the Art: Cas9 for Gene Activation and Repression. Mol Cell Biol (2015) 0.87
Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells. Nucleic Acids Res (2001) 0.84
Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors. J Biol Chem (2012) 0.84
Induction of Fetal Hemoglobin In Vivo Mediated by a Synthetic γ-Globin Zinc Finger Activator. Anemia (2012) 0.84
Designed transcription factors as structural, functional and therapeutic probes of chromatin in vivo. Fourth in review series on chromatin dynamics. EMBO Rep (2002) 0.84
Light-inducible gene regulation with engineered zinc finger proteins. Methods Mol Biol (2014) 0.83
Genome editing comes of age. Nat Protoc (2016) 0.81
Tailor-made zinc-finger transcription factors activate FLO11 gene expression with phenotypic consequences in the yeast Saccharomyces cerevisiae. PLoS One (2007) 0.81
The simple and rapid detection of specific PCR products from bacterial genomes using Zn finger proteins. Nucleic Acids Res (2008) 0.81
Epigenetic manipulation of gene expression: a toolkit for cell biologists. J Cell Biol (2005) 0.81
Viral hybrid vectors for somatic integration - are they the better solution? Viruses (2009) 0.81
Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer. Br J Cancer (2013) 0.81
Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter. Mol Ther (2016) 0.81
Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases. Neurotherapeutics (2014) 0.80
Engineering protocells: prospects for self-assembly and nanoscale production-lines. Life (Basel) (2015) 0.80
Assembly and validation of versatile transcription activator-like effector libraries. Sci Rep (2014) 0.80
Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology. Mol Cell Biol (2005) 0.79
Upregulating endogenous genes by an RNA-programmable artificial transactivator. Nucleic Acids Res (2015) 0.79
Suppression of gene expression by a cell-permeable Tet repressor. Nucleic Acids Res (2003) 0.78
Control of enzyme reaction by a designed metal-ion-dependent α-helical coiled-coil protein. J Biol Inorg Chem (2012) 0.78
Crystallization and preliminary X-ray crystallographic analysis of Aart, a designed six-finger zinc-finger peptide, bound to DNA. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.77
Design of a zinc finger protein binding a sequence upstream of the A20 gene. BMC Biotechnol (2008) 0.77
Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases. World J Hepatol (2015) 0.77
Tra1 as a screening target for transcriptional activation domain discovery. Bioorg Med Chem Lett (2009) 0.77
Re-programming DNA-binding specificity in zinc finger proteins for targeting unique address in a genome. Syst Synth Biol (2011) 0.76
An efficient and cost-effective protocol for selecting transcription factor binding sites that reduces isotope usage. J Biomol Tech (2012) 0.76
Electrostatic control of half-site spacing preferences by the cyclic AMP response element-binding protein CREB. Nucleic Acids Res (2001) 0.76
CRISPR-Mediated Epigenome Editing. Yale J Biol Med (2016) 0.75
The new biology. Genomics fosters a "systems approach" and collaborations between academic, government, and industry scientists. Plant Cell (2001) 0.75
RNA activation of haploinsufficient Foxg1 gene in murine neocortex. Sci Rep (2016) 0.75
Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domain. ACS Synth Biol (2014) 0.75
Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nat Rev Neurol (2017) 0.75
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A (1992) 35.45
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science (1987) 6.36
Zinc finger phage: affinity selection of fingers with new DNA-binding specificities. Science (1994) 5.70
Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A (1998) 5.46
A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites. Science (1997) 4.93
The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta (1994) 4.92
Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5'-GNN-3' DNA target sequences. Proc Natl Acad Sci U S A (1999) 4.87
Krüppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A (1994) 4.84
Toward a code for the interactions of zinc fingers with DNA: selection of randomized fingers displayed on phage. Proc Natl Acad Sci U S A (1994) 4.57
Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A (1989) 4.17
Toward rules relating zinc finger protein sequences and DNA binding site preferences. Proc Natl Acad Sci U S A (1992) 4.15
Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene (1995) 4.10
Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. EMBO J (1992) 4.05
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature (1991) 3.98
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J (1999) 3.79
p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol (1989) 3.62
Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci U S A (1990) 3.11
Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA binding proteins. Proc Natl Acad Sci U S A (1993) 3.09
Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci U S A (1997) 2.97
Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci U S A (1997) 2.97
Building zinc fingers by selection: toward a therapeutic application. Proc Natl Acad Sci U S A (1995) 2.92
The Tetrahymena ribozyme acts like an RNA restriction endonuclease. Nature (1987) 2.53
Regulation of gene expression by small molecules. Nature (1997) 2.27
Imposing specificity by localization: mechanism and evolvability. Curr Biol (1998) 2.13
Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol Cell Biol (1995) 2.13
Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Oncogene (2000) 2.01
Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc Natl Acad Sci U S A (1993) 1.64
Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists. J Biol Chem (1992) 1.58
Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J Cell Biochem (1989) 1.43
Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells. Cancer Res (1997) 1.41
In pursuit of antisense. Nature (1996) 1.15
Cloning and characterization of the mouse neu promoter. Oncogene (1992) 1.08
Transcriptional regulation: contending with complexity. Proc Natl Acad Sci U S A (1999) 1.03
Combinatorial gene regulation by eukaryotic transcription factors. Curr Opin Struct Biol (1999) 1.03
Intracellular single-chain antibody directed against erbB2 down-regulates cell surface erbB2 and exhibits a selective anti-proliferative effect in erbB2 overexpressing cancer cell lines. Gene Ther (1994) 0.96
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol (1995) 6.33
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci U S A (1991) 6.13
Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A (1998) 5.46
Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5'-GNN-3' DNA target sequences. Proc Natl Acad Sci U S A (1999) 4.87
Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes. Science (1995) 3.82
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med (1997) 3.63
Development of zinc finger domains for recognition of the 5'-ANN-3' family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem (2001) 3.35
Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci U S A (1997) 2.97
Building zinc fingers by selection: toward a therapeutic application. Proc Natl Acad Sci U S A (1995) 2.92
Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci U S A (1991) 2.42
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J Virol (1998) 2.28
In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A (1992) 2.08
Insights into the molecular recognition of the 5'-GNN-3' family of DNA sequences by zinc finger domains. J Mol Biol (2000) 2.03
Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci U S A (1993) 2.01
CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol (1995) 1.90
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding. AIDS Res Hum Retroviruses (1996) 1.87
Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses (1997) 1.84
Human antibodies from combinatorial libraries. Adv Immunol (1994) 1.78
Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off. J Virol (1997) 1.66
Phage display of combinatorial antibody libraries. Curr Opin Biotechnol (1997) 1.56
Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12. J Virol (2001) 1.53
Custom DNA-binding proteins come of age: polydactyl zinc-finger proteins. Curr Opin Biotechnol (2001) 1.52
Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature (1992) 1.50
Human combinatorial antibody libraries to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1992) 1.43
Antibodies without immunization. Science (1992) 1.41
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci U S A (1994) 1.40
Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc Natl Acad Sci U S A (2000) 1.40
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J Immunol (1995) 1.39
T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery. Gene Ther (2006) 1.38
Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis. Proc Natl Acad Sci U S A (1998) 1.37
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. J Mol Biol (1997) 1.33
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J Biol Chem (2000) 1.32
Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis (1998) 1.29
Chemically regulated zinc finger transcription factors. J Biol Chem (2000) 1.29
In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope. J Virol (1996) 1.28
Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods (2000) 1.27
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Hum Retroviruses (1997) 1.26
Multiple event activation of a generic prodrug trigger by antibody catalysis. Proc Natl Acad Sci U S A (1999) 1.21
An allosteric Ca2+ binding site on the beta3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem (1996) 1.14
A binary plasmid system for shuffling combinatorial antibody libraries. Proc Natl Acad Sci U S A (1992) 1.11
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology (1998) 1.08
Design of novel sequence-specific DNA-binding proteins. Curr Opin Chem Biol (2000) 1.07
Catalytic direct asymmetric Michael reactions: taming naked aldehyde donors. Org Lett (2001) 1.07
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy. Proc Natl Acad Sci U S A (2001) 1.04
Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules. J Virol (1996) 1.03
Antibodies from libraries. Nature (1992) 1.02
Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1. Acta Crystallogr D Biol Crystallogr (2001) 1.01
On the use of combinatorial antibody libraries to clone the "fossil record" of an individual's immune response. Proc Natl Acad Sci U S A (1991) 0.98
Molecular cloning, nucleotide sequence and fine-structural analysis of the Corynebacterium glutamicum fda gene: structural comparison of C. glutamicum fructose-1,6-biphosphate aldolase to class I and class II aldolases. Mol Microbiol (1989) 0.96
The antibody catalysis route to the total synthesis of epothilones. Proc Natl Acad Sci U S A (1998) 0.96
Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. Am J Hematol (2001) 0.95
Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization. J Biol Chem (2000) 0.95
The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries. Anal Biochem (1998) 0.95
The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A (1994) 0.94
Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein. Mol Med (1998) 0.93
Human antibodies to HIV-1 by recombinant DNA methods. Chem Immunol (1993) 0.92
On roads not taken in the evolution of protein catalysts: antibody steroid isomerases that use an enamine mechanism. Proc Natl Acad Sci U S A (1997) 0.91
Direct selection for a catalytic mechanism from combinatorial antibody libraries. Proc Natl Acad Sci U S A (1994) 0.90
Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther (2008) 0.90
A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. Proc Natl Acad Sci U S A (1998) 0.90
Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task. Proc Natl Acad Sci U S A (2000) 0.89
Identification of a region in the integrin beta3 subunit that confers ligand binding specificity. J Biol Chem (1997) 0.89
Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol (2001) 0.86
Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human alpha-granules. Gene (1996) 0.84
Surface plasmon resonance based kinetic studies of zinc finger-DNA interactions. J Immunol Methods (1995) 0.84
An efficient benchtop system for multigram-scale kinetic resolutions using aldolase antibodies. Chemistry (2000) 0.84
Building synthetic antibodies as adhesive ligands for integrins. J Biol Chem (1994) 0.83
Benzoate X receptor zinc-finger gene switches for drug-inducible regulation of transcription. Gene Ther (2011) 0.83
Human monoclonal antibodies: recent achievements. Hosp Pract (Off Ed) (1994) 0.83
Sets of aldolase antibodies with antipodal reactivities. Formal synthesis of epothilone E by large-scale antibody-catalyzed resolution of thiazole aldol. Org Lett (1999) 0.82
Isolation of two interleukin-6 response element binding proteins from acute phase rat livers. Ann N Y Acad Sci (1995) 0.82
Deodorants on the European market: quantitative chemical analysis of 21 fragrances. Contact Dermatitis (1998) 0.79
Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer. Cancer Lett (2001) 0.78
Deodorants: a clinical provocation study in fragrance-sensitive individuals. Contact Dermatitis (1998) 0.77
Visualizing antibody-catalyzed retro-aldol-retro-Michael reactions. Bioorg Med Chem Lett (2001) 0.76
Making enzymes. Harvey Lect (2004) 0.76
Synthesis of five enantiomerically pure haptens designed for in vitro evolution of antibodies with peptidase activity. Bioorg Med Chem (1996) 0.76
Alchemy, enzymes, and the blind-watchmaker. Nat Biotechnol (1998) 0.75
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis. Proc Natl Acad Sci U S A (2001) 0.75
[Prurigo pigmentosa]. Hautarzt (1997) 0.75
Retracted Simultaneous, phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody enhances antiangiogenic effects in vivo. Klin Padiatr (2006) 0.75
Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA libraries. Immunotechnology (1995) 0.75
Using the process of reactive immunization to induce catalytic antibodies with complex mechanisms: aldolases. Acta Chem Scand (1996) 0.75
Purification of storage granule protein-23. A novel protein identified by phage display technology and interaction with type I plasminogen activator inhibitor. J Biol Chem (1996) 0.75
Enantioselective aldol cyclodehydrations catalyzed by antibody 38C2. Org Lett (1999) 0.75
Fragrances and other materials in deodorants: search for potentially sensitizing molecules using combined GC-MS and structure activity relationship (SAR) analysis. Contact Dermatitis (1998) 0.75
The repeated open application test: suggestions for a scale of evaluation. Contact Dermatitis (1998) 0.75